The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.
SBC: Path Ex, Inc. Topic: BM
The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to develop a dialysis-like platform for selective bacterial separation and removal from blood. This technology could potentially serve as a novel blood cleansing therapy for the treatment of disease, including sepsis. Sepsis, a life threatening organ dysfunction caused by infection, is a co ...STTR Phase I 2017 National Science Foundation
Enabling point of care molecular diagnostics by developing an adaptive PCR instrument and on demand kit reagentsSBC: BIOVENTURES, INC Topic: 172
Because of its high sensitivity polymerase chain reaction PCR is the gold standard for the diagnosis of many infectious diseases but generally only implemented in well equipped laboratories One of the major roadblocks for expanding PCR to point of care markets is the lack of simple robust single tube PCR designs which preserve its laboratory based high sensitivity and specificity In this F ...STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
STTR Phase I: Specialized high resolution imaging system for rapid batch screening of aflatoxin in cornSBC: SECURE FOOD SOLUTIONS, INCORPORATED Topic: BT
The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project will be commercially deployable equipment for screening, detecting, and removing aflatoxin contaminated corn from the global food supply. Exposure to aflatoxin, a dangerous fungal carcinogen, has been linked to liver cancer, childhood stunting, illness and death in humans and animals, and majo ...STTR Phase I 2017 National Science Foundation